US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Eisai Co., Ltd.

7.75

+0.745010.64%

Post-market: 7.750.00000.00%16:00 EST

Volume:118.86K

Turnover:922.62K

Market Cap:8.82B

PE:43.79

High:7.78

Open:7.70

Low:7.55

Close:7.01

52wk High:9.22

52wk Low:5.94

Shares:1.14B

Float Shares:1.08B

Volume Ratio:0.85

T/O Rate:0.01%

Dividend:0.27

Dividend Rate:3.45%

EPS(TTM):0.1770

EPS(LYR):0.2444

ROE:4.89%

ROA:2.12%

PB:1.52

PE(LYR):31.71

Loading ...

Overview Company News Filings

Eisai, Biogen announces FDA accepted to review the sBLA for lecanemab-irmb

Nuvation Bio, Eisai enter exclusive taletrectinib license agreement

The miracle of curing Alzheimer's? No longer an impossibility.

This Medicare premium just crossed $200 for the first time. Here's why.

Eisai, Biogen announces Health Canada granted authorization for ‘LEQEMBI’

Merck, Eisai announce follow-up data on KEYTRUDA plus LENVIMA

Eisai, Biogen announce U.S. availability of LEQEMBI IQLIK

Eisai, Biogen announce LEQEMBI approved by NMPA in China

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ESAIY/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ESAIY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESAIY\",,,,,undefined,":{"symbol":"ESAIY","market":"US","secType":"STK","nameCN":"Eisai Co., Ltd.","latestPrice":7.75,"timestamp":1770757200000,"preClose":7.005,"halted":0,"volume":118864,"hourTrading":{"tag":"盘后","latestPrice":7.75,"preClose":7.75,"latestTime":"16:00 EST","volume":152,"amount":1178,"timestamp":1770757238253,"change":0,"changeRate":0,"amplitude":0},"delay":15,"changeRate":0.10635260528194149,"floatShares":1076747898,"shares":1137465824,"eps":0.176978,"marketStatus":"Closed","change":0.745,"latestTime":"02-10 16:00:38 EST Delay","open":7.7,"high":7.78,"low":7.55,"amount":922616.9088000003,"amplitude":0.032834,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.176978,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770800400000},"marketStatusCode":5,"adr":0,"adrRate":0.25,"exchange":"PINK LIMITED","adjPreClose":7.005,"volumeRatio":0.853673},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESAIY\",,,,,undefined,":{"symbol":"ESAIY","floatShares":1076747898,"roa":"2.12%","roe":"4.89%","lyrEps":0.244385,"volumeRatio":0.853673,"shares":1137465824,"dividePrice":0.267,"high":7.78,"amplitude":0.032834,"preClose":7.005,"low":7.55,"week52Low":5.94,"pbRate":"1.52","psRate":"1.68","week52High":9.22,"institutionHeld":0,"latestPrice":7.75,"eps":0.176978,"divideRate":0.034452,"volume":118864,"delay":15,"ttmEps":0.176978,"open":7.7,"prevYearClose":7.38,"prevWeekClose":7.35,"prevMonthClose":6.91,"prevQuarterClose":7.38,"fiveDayClose":6.94,"twentyDayClose":7.62,"sixtyDayClose":7.11},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ESAIY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-06","symbol":"ESAIY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"post","actualEps":null},{"date":"2024-08-01","symbol":"ESAIY","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722542400000,"name":null,"time":"Post Market","dateTimestamp":1722484800000,"actualEps":null},{"date":"2024-05-14","symbol":"ESAIY","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715716800000,"name":null,"time":"Post Market","dateTimestamp":1715659200000,"actualEps":null},{"market":"US","date":"2024-02-05","symbol":"ESAIY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1707109200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-07","symbol":"ESAIY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1699333200000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ESAIY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ESAIY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1333,"buy":0.1333,"hold":0.6667,"sell":0.0667,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6667,"analysts":15,"updateTime":1769490000000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ESAIY\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606267013","title":"Eisai, Biogen announces FDA accepted to review the sBLA for lecanemab-irmb","url":"https://stock-news.laohu8.com/highlight/detail?id=2606267013","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606267013?lang=en_us&edition=fundamental","pubTime":"2026-01-26 10:15","pubTimestamp":1769393716,"startTime":"0","endTime":"0","summary":"Eisai (ESAIY) and Biogen (BIIB) announced that the U.S. Food and Drug Administration, FDA, has accepted for review Eisai’s Supplemental Biologics L...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announces-fda-accepted-to-review-the-sbla-for-lecanemab-irmb-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announces-fda-accepted-to-review-the-sbla-for-lecanemab-irmb-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","IE00B894F039.SGD","IE00B19Z9P08.USD","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","BIIB","BK4007","BK4532","IE00B19Z9Z06.USD","BK4585","ESAIY","BK4588","BK4139","LU0234570918.USD"],"gpt_icon":0},{"id":"2602100775","title":"Nuvation Bio, Eisai enter exclusive taletrectinib license agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2602100775","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602100775?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:06","pubTimestamp":1768223197,"startTime":"0","endTime":"0","summary":"Nuvation Bio (NUVB) and Eisai (ESAIY) announced an exclusive license and collaboration agreement that significantly expands the long-term global fo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvation-bio-eisai-enter-exclusive-taletrectinib-license-agreement-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvation-bio-eisai-enter-exclusive-taletrectinib-license-agreement-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ESAIY","NUVB"],"gpt_icon":0},{"id":"2595732211","title":"The miracle of curing Alzheimer's? No longer an impossibility.","url":"https://stock-news.laohu8.com/highlight/detail?id=2595732211","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595732211?lang=en_us&edition=fundamental","pubTime":"2025-12-30 02:21","pubTimestamp":1767032460,"startTime":"0","endTime":"0","summary":"More research shows the disease may one day be reversible. Recent science on Alzheimer's disease provides cause for optimism.A new scientific breakthrough in the field of Alzheimer's research is raising hopes that the cruel, crippling and fatal brain disease may eventually become curable.An international team of more than 35 scientists from some of the world's leading institutions have published new research showing \"proof of principle\" that advanced Alzheimer's disease - often characterized not only by the loss of memory and executive function, but of one's actual personality - could be \"reversible.\". \"Alzheimer's disease can be reversed to achieve full neurological recovery - not just prevented or slowed - in animal models,\" according to researchers at Case Western Reserve University in Cleveland, whose scientists helped lead the investigation.Mice who were administered a regular course of a pharmacological agent called P7C3-A20 experienced \"full cognitive recovery\" even if they alre","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B894F039.SGD","IE00B19Z9Z06.USD","LU0109394709.USD","BK4139","LU0234570918.USD","BK4533","BK4007","LU0889565916.HKD","ESAIY","IE00B19Z9P08.USD","LU0320765992.SGD","BK4532","BK4588","BK4585","BIIB"],"gpt_icon":0},{"id":"2585172253","title":"This Medicare premium just crossed $200 for the first time. Here's why.","url":"https://stock-news.laohu8.com/highlight/detail?id=2585172253","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585172253?lang=en_us&edition=fundamental","pubTime":"2025-11-22 21:30","pubTimestamp":1763818200,"startTime":"0","endTime":"0","summary":"The 9.7% increase in the cost of Medicare Part B premiums for 2026 is due to several factors, including projected growth in Medicare Advantage and outpatient care next year. Medicare Part B premiums are going up by 9.7% in 2026.Blame medical inflation and more people in need of costly care for the 9.7% jump in Medicare Part B premiums next year.Starting in January, people on Medicare will pay $202.90 in 2026 for their monthly Part B premiums, which provide coverage for services like doctor's visits, outpatient procedures and medications administered by a healthcare professional. That's up from $185.00 in 2025.The government has a simple explanation for the largest-ever dollar increase for these premiums, citing \"projected growth in overall healthcare spending.\" Medicare's spending growth is supposed to increase 8.9% across 2026 and 2027, outpacing the 5.6% jump in predicted health spending growth in general.Plus, more care is moving from inpatient settings to less expensive outpatient ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU0320765646.SGD","LU1941712348.USD","REGN","IE00BLSP4452.SGD","LU1023059063.AUD","LU2461242641.AUD","CMS","SG9999001176.SGD","LU1571399168.USD","BK4139","LU1934455863.HKD","LU1035773651.USD","LU1430594728.SGD","ESAIY","LU0965508806.USD","LU0965509101.SGD","LU2346227817.USD","LU2468319806.SGD","BIIB","LU2106854487.HKD","IE00BSNM7G36.USD","BK4588","LU1066051498.USD","BK4550","LU2362540622.SGD","LU0106261372.USD","IE00BBT3K403.USD","MRK","SG9999002224.SGD","BK4516","LU0208291251.USD","IE00B1BXHZ80.USD","IE00B4R5TH58.HKD","SG9999002232.USD","LU0122379950.USD","LU2361045086.USD","BK4585","LU1917777945.USD","IE00BLSP4239.USD","LU1069347547.HKD","LU1093756325.SGD","LU1093756168.USD","LU0265550946.USD","LU0553294199.USD","BK4559","LU2362541273.HKD","LU0823416689.USD","LU0070302665.USD","LU0985320562.USD"],"gpt_icon":0},{"id":"2578666765","title":"Eisai, Biogen announces Health Canada granted authorization for ‘LEQEMBI’","url":"https://stock-news.laohu8.com/highlight/detail?id=2578666765","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578666765?lang=en_us&edition=fundamental","pubTime":"2025-10-27 08:20","pubTimestamp":1761524408,"startTime":"0","endTime":"0","summary":"Eisai (ESAIY) and Biogen (BIIB) announced that Health Canada has issued a Notice of Compliance with Conditions for humanized anti-soluble aggregate...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announces-health-canada-granted-authorization-for-leqembi-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announces-health-canada-granted-authorization-for-leqembi-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","LU0320765992.SGD","LU0889565916.HKD","BK4532","BK4533","ESAIY","IE00B894F039.SGD","BK4585","LU0234570918.USD","BIIB","LU0109394709.USD","BK4007","BK4588"],"gpt_icon":0},{"id":"2576071115","title":"Merck, Eisai announce follow-up data on KEYTRUDA plus LENVIMA","url":"https://stock-news.laohu8.com/highlight/detail?id=2576071115","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576071115?lang=en_us&edition=fundamental","pubTime":"2025-10-19 22:35","pubTimestamp":1760884506,"startTime":"0","endTime":"0","summary":"Merck (MRK) and Eisai (ESAIY) announced long-term follow-up data continued to show durable benefit of KEYTRUDA, Merck’s anti-PD-1 therapy, plus LEN...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/merck-eisai-announce-follow-up-data-on-keytruda-plus-lenvima-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/merck-eisai-announce-follow-up-data-on-keytruda-plus-lenvima-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2106854487.HKD","LU1989772923.USD","LU1093756168.USD","SG9999013999.USD","LU0238689110.USD","IE000M9KFDE8.USD","LU2461242641.AUD","LU0234572021.USD","LU1941712264.USD","IE00BLSP4452.SGD","LU1974910355.USD","BK4588","SG9999014542.SGD","IE0009355771.USD","SGXZ57979304.SGD","LU0203345920.USD","BK4516","LU1023059063.AUD","ESAIY","LU1989771016.USD","SG9999002224.SGD","IE00BJJMRZ35.SGD","LU0265550946.USD","LU1934455194.USD","LU0106261372.USD","LU1430594728.SGD","SG9999001176.SGD","LU1934455277.USD","BK4585","BK4534","LU2361045086.USD","LU1035773651.USD","LU0289739699.SGD","LU1066051811.HKD","LU0208291251.USD","LU1941712348.USD","LU0320765646.SGD","SG9999001440.SGD","LU2089984988.USD","LU1116320901.HKD","SG9999015358.SGD","LU1066051225.USD","IE00B4R5TH58.HKD","IE00BBT3K403.USD","IE00BLSP4239.USD","MRK","SG9999002232.USD","LU1989772840.SGD","BK4550","LU0320765489.SGD"],"gpt_icon":0},{"id":"2573983098","title":"Eisai, Biogen announce U.S. availability of LEQEMBI IQLIK","url":"https://stock-news.laohu8.com/highlight/detail?id=2573983098","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573983098?lang=en_us&edition=fundamental","pubTime":"2025-10-07 04:35","pubTimestamp":1759782939,"startTime":"0","endTime":"0","summary":"Eisai Co. (ESAIY) and Biogen (BIIB) announced that lecanemab-irmb subcutaneous injection, U.S. brand name: LEQEMBI IQLIKTM, is now available in the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announce-u-s-availability-of-leqembi-iqlik-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announce-u-s-availability-of-leqembi-iqlik-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","IE00B894F039.SGD","IE00B19Z9Z06.USD","LU0109394709.USD","LU0320765992.SGD","ESAIY","IE00B19Z9P08.USD","LU0889565916.HKD","BK4585","BK4588","LU0234570918.USD","BK4139","BIIB","BK4533","BK4007"],"gpt_icon":0},{"id":"2571878242","title":"Eisai, Biogen announce LEQEMBI approved by NMPA in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2571878242","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571878242?lang=en_us&edition=fundamental","pubTime":"2025-09-29 07:35","pubTimestamp":1759102505,"startTime":"0","endTime":"0","summary":"Eisai (ESAIY) and Biogen (BIIB) announced that humanized anti-soluble aggregated amyloid-beta monoclonal antibody “LEQEMBI” has been approved for o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announce-leqembi-approved-by-nmpa-in-china-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announce-leqembi-approved-by-nmpa-in-china-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B894F039.SGD","LU0320765992.SGD","IE00B19Z9Z06.USD","BK4532","BK4533","LU0234570918.USD","IE00B19Z9P08.USD","BK4588","BK4139","BK4007","BK4585","LU0889565916.HKD","BIIB","ESAIY","LU0109394709.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}